SELLAS Life Sciences Group
$5.37
211
+$0.34+6.76% Friday 20:00
Statistics
Day High
5.6
Day Low
5.11
52W High
6.14
52W Low
0.95
Volume
6,066,391
Avg. Volume
9,025,741
Mkt Cap
764.91M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Dividends
0%Dividend Yield
Apr 11
$12.02
Dec 10
$21.07
Sep 10
$7.5
Jun 10
$4.25
Mar 10
$4.25
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A
Earnings
19MayExpected
Expected EPS
-0.075
Actual EPS
N/A
Financials
-Profit Margin
Unprofitable0Revenue
-61.76MNet Income
People Also Follow
This list is based on the watchlists of people on Stock Events who follow SLS. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Novartis
NVS
Mkt Cap237.61B
Merck
MRK
Mkt Cap214.76B
Bristol-Myers Squibb
BMY
Mkt Cap93.79B
Pfizer
PFE
Mkt Cap140.15B
AMGEN
AMGN
Mkt Cap160.66B
Astrazeneca
AZN
Mkt Cap256.58B
About
SELLAS Life Sciences Group, Inc., a late-stage clinical biopharmaceutical company, focuses on the development of novel therapeutics for various cancer indications in the United States. The company's lead product candidate is galinpepimut-S (GPS), a peptide immunotherapy directed against the Wilms tumor 1, antigen; and SLS009 (tambiciclib), a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor. It has a strategic collaboration with Merck & Co., Inc. to evaluate GPS as it is administered in combination with PD1 blocker pembrolizumab in a Phase 1/2 clinical trial enrolling patients in up to five cancer indications, including hematologic malignancies and solid tumors; and GenFleet Therapeutics (Shanghai), Inc. for the development and commercialization of GFH009. SELLAS Life Sciences Group, Inc. is headquartered in New York, New York.
Show more...
CEO
Dr. Angelos M. Stergiou M.D., ScD h.c.
Employees
15
Country
US
ISIN
US81642T2096
Listings
0 Comments
Share your thoughts
FAQ
What is SELLAS Life Sciences Group stock price today?▼
The current price of SLS is $5.37 USD — it has increased by +6.76% in the past 24 hours. Watch SELLAS Life Sciences Group stock price performance more closely on the chart.
What is SELLAS Life Sciences Group stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange SELLAS Life Sciences Group stocks are traded under the ticker SLS.
Is SELLAS Life Sciences Group stock price growing?▼
SLS stock has fallen by -2.89% compared to the previous week, the month change is a +49.58% rise, over the last year SELLAS Life Sciences Group has showed a +371.05% increase.
What is SELLAS Life Sciences Group market cap?▼
Today SELLAS Life Sciences Group has the market capitalization of 764.91M
When is the next SELLAS Life Sciences Group earnings date?▼
SELLAS Life Sciences Group is going to release the next earnings report on March 16, 2026.
What were SELLAS Life Sciences Group earnings last quarter?▼
SLS earnings for the last quarter are -0.06 USD per share, whereas the estimation was -0.08 USD resulting in a +21.74% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is SELLAS Life Sciences Group revenue for the last year?▼
SELLAS Life Sciences Group revenue for the last year amounts to 0 USD.
What is SELLAS Life Sciences Group net income for the last year?▼
SLS net income for the last year is -61.76M USD.
Does SELLAS Life Sciences Group pay dividends?▼
Yes, SLS dividends are paid quarterly. The last dividend per share was 12.02 USD. As of today, Dividend Yield (FWD)% is 0%.
How many employees does SELLAS Life Sciences Group have?▼
As of March 15, 2026, the company has 15 employees.
In which sector is SELLAS Life Sciences Group located?▼
SELLAS Life Sciences Group operates in the Health Care sector.
When did SELLAS Life Sciences Group complete a stock split?▼
The last stock split for SELLAS Life Sciences Group was on November 08, 2019 with a ratio of 1:50.
Where is SELLAS Life Sciences Group headquartered?▼
SELLAS Life Sciences Group is headquartered in New York, US.